Principles of an Adenovirus-Based Assay for Candidate Compounds with Broad Spectrum of Anti-Neoplastic Activities

Author(s): Mikhail V. Shepelev, Elena V. Korobko, Igor V. Korobko

Journal Name: Letters in Drug Design & Discovery

Volume 13 , Issue 10 , 2016

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Several classes of anti-neoplastic drugs, in particular, those targeting protein kinase mTOR, topoisomerases and histone deacetylases, along with yet unknown pathways which inhibition is beneficial in cancer treatment, can augment expression of encoded by recombinant adenoviruses transgenes. We used enhancement of transgene expression encoded by recombinant adenovirus as a sensor enabling simultaneous identification of compounds with the above-mentioned diverse activities, and developed principles of screening assay for primary identification of candidate compounds with anti-neoplastic properties. The assay is suited for high-throughput application, with homogeneous format and green/blue fluorescence readout.

Keywords: Cancer drug discovery, recombinant replication-deficient adenovirus, mTOR, topoisomerase, histone deacetylase inhibitors, high-throughput screening, fluorescent detection.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 10
Year: 2016
Page: [1007 - 1011]
Pages: 5
DOI: 10.2174/1570180813666160422162612
Price: $65

Article Metrics

PDF: 22
HTML: 2
EPUB: 1
PRC: 1